company background image
A206640 logo

Boditech Med KOSDAQ:A206640 Stock Report

Last Price

₩16.30k

Market Cap

₩358.2b

7D

-3.1%

1Y

-21.4%

Updated

21 Dec, 2024

Data

Company Financials +

Boditech Med Inc.

KOSDAQ:A206640 Stock Report

Market Cap: ₩358.2b

A206640 Stock Overview

Offers instruments and diagnostic reagents in South Korea and internationally. More details

A206640 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance4/6
Financial Health6/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Boditech Med Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Boditech Med
Historical stock prices
Current Share Price₩16,300.00
52 Week High₩21,500.00
52 Week Low₩13,350.00
Beta-0.64
1 Month Change3.16%
3 Month Change-10.93%
1 Year Change-21.45%
3 Year Change-0.91%
5 Year Change68.91%
Change since IPO-70.70%

Recent News & Updates

Risks Still Elevated At These Prices As Boditech Med Inc. (KOSDAQ:206640) Shares Dive 26%

Oct 14
Risks Still Elevated At These Prices As Boditech Med Inc. (KOSDAQ:206640) Shares Dive 26%

Boditech Med (KOSDAQ:206640) Has More To Do To Multiply In Value Going Forward

Oct 11
Boditech Med (KOSDAQ:206640) Has More To Do To Multiply In Value Going Forward

Recent updates

Risks Still Elevated At These Prices As Boditech Med Inc. (KOSDAQ:206640) Shares Dive 26%

Oct 14
Risks Still Elevated At These Prices As Boditech Med Inc. (KOSDAQ:206640) Shares Dive 26%

Boditech Med (KOSDAQ:206640) Has More To Do To Multiply In Value Going Forward

Oct 11
Boditech Med (KOSDAQ:206640) Has More To Do To Multiply In Value Going Forward

Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Sep 13
Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Jul 12
Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth

Apr 16
Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth

Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today

Apr 13
Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today

Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?

Mar 01
Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?

Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly

Jan 18
Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly

Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock

Dec 28
Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock

Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?

Dec 08
Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?

Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Nov 18
Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Shareholder Returns

A206640KR Medical EquipmentKR Market
7D-3.1%-3.3%-3.7%
1Y-21.4%-3.1%-10.4%

Return vs Industry: A206640 underperformed the KR Medical Equipment industry which returned -3.1% over the past year.

Return vs Market: A206640 underperformed the KR Market which returned -10.4% over the past year.

Price Volatility

Is A206640's price volatile compared to industry and market?
A206640 volatility
A206640 Average Weekly Movement7.5%
Medical Equipment Industry Average Movement7.3%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.7%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A206640 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A206640's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998491n/awww.boditech.co.kr/en

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges; ichroma-50, an automated immunoassay system with high-throughput; Hemochroma PLUS, a handheld device that can run tests for anemia; portable analyzers ichroma M3 and ichroma M2; and NuActor, an automated nucleic acid extraction system. It also provides compact immunoassay analyzers, including AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10; cardiac reagents; cancer reagents; COVID-19 reagents; diagnostic reagents; reagents for hormones, infections, autoimmune, organ functions, molecular diagnostics, therapeutic drug monitoring, and other test items.

Boditech Med Inc. Fundamentals Summary

How do Boditech Med's earnings and revenue compare to its market cap?
A206640 fundamental statistics
Market cap₩358.22b
Earnings (TTM)₩27.30b
Revenue (TTM)₩141.86b

13.1x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A206640 income statement (TTM)
Revenue₩141.86b
Cost of Revenue₩55.28b
Gross Profit₩86.58b
Other Expenses₩59.28b
Earnings₩27.30b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.24k
Gross Margin61.03%
Net Profit Margin19.24%
Debt/Equity Ratio1.7%

How did A206640 perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

16%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 23:59
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boditech Med Inc. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyung Soo KimCape Investment & Securities Co., Ltd.
Changhee WooIBK Securities Co. Ltd.
JooYong KimKiwoom Securities Co., Ltd.